Kelly M - Search Results

1

Extrarenal Wilms' tumor of the uterine corpus.

McAlpine J, Azodi M, O'Malley D, Kelly M, Golenewsky G, Martel M, Rutherford T, Tavassoli F. McAlpine J, et al. Among authors: kelly m. Gynecol Oncol. 2005 Mar;96(3):892-6. doi: 10.1016/j.ygyno.2004.11.029. Gynecol Oncol. 2005. PMID: 15721447 Review.

2

Minimal uterine serous carcinoma: a clinicopathological study of 40 cases.

Hui P, Kelly M, O'Malley DM, Tavassoli F, Schwartz PE. Hui P, et al. Among authors: kelly m. Mod Pathol. 2005 Jan;18(1):75-82. doi: 10.1038/modpathol.3800271. Mod Pathol. 2005. PMID: 15389257 Free article.

3

Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.

Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE. Kelly MG, et al. Gynecol Oncol. 2004 Dec;95(3):469-73. doi: 10.1016/j.ygyno.2004.08.030. Gynecol Oncol. 2004. PMID: 15581948

4

Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma.

O'Malley DM, Azodi M, Makkenchery A, Tangir J, McAlpine J, Kelly M, Schwartz P, Rutherford T. O'Malley DM, et al. Among authors: kelly m. Gynecol Oncol. 2005 Aug;98(2):242-8. doi: 10.1016/j.ygyno.2005.04.032. Gynecol Oncol. 2005. PMID: 15992916

5

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.

Kelly MG, O'malley DM, Hui P, McAlpine J, Yu H, Rutherford TJ, Azodi M, Schwartz PE. Kelly MG, et al. Gynecol Oncol. 2005 Sep;98(3):353-9. doi: 10.1016/j.ygyno.2005.06.012. Gynecol Oncol. 2005. PMID: 16005947

6

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.

Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S, Visintin I, Rutherford T, Mor G. Kelly MG, et al. Cancer Res. 2006 Apr 1;66(7):3859-68. doi: 10.1158/0008-5472.CAN-05-3948. Cancer Res. 2006. PMID: 16585214

7

Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies.

McAlpine JN, Kelly MG, O'malley DM, Azodi M, Coombe K, Schwartz PE, Rutherford TJ. McAlpine JN, et al. Among authors: kelly mg. Gynecol Oncol. 2006 Oct;103(1):288-92. doi: 10.1016/j.ygyno.2006.03.007. Epub 2006 May 2. Gynecol Oncol. 2006. PMID: 16647749

8

Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.

Hou JY, Kelly MG, Yu H, McAlpine JN, Azodi M, Rutherford TJ, Schwartz PE. Hou JY, et al. Among authors: kelly mg. Gynecol Oncol. 2007 Apr;105(1):211-7. doi: 10.1016/j.ygyno.2006.11.025. Epub 2007 Jan 18. Gynecol Oncol. 2007. PMID: 17239941

9

Carcinosarcoma of the ovary.

Silasi DA, Illuzzi JL, Kelly MG, Rutherford TJ, Mor G, Azodi M, Schwartz PE. Silasi DA, et al. Among authors: kelly mg. Int J Gynecol Cancer. 2008 Jan-Feb;18(1):22-9. doi: 10.1111/j.1525-1438.2007.00948.x. Epub 2007 Apr 19. Int J Gynecol Cancer. 2008. PMID: 17451459

10

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.

Silasi DA, Alvero AB, Illuzzi J, Kelly M, Chen R, Fu HH, Schwartz P, Rutherford T, Azodi M, Mor G. Silasi DA, et al. Among authors: kelly m. Yale J Biol Med. 2006 Dec;79(3-4):153-63. Yale J Biol Med. 2006. PMID: 17940625 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,556 results

Search Page

Filters